CytoMed Therapeutics Limited reported earnings results for the half year ended June 30, 2023. For the half year, the company reported net loss was SGD 2.16 million compared to SGD 0.995287 million a year ago. Basic loss per share from continuing operations was SGD 0.22 compared to SGD 0.13 a year ago.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.02 USD | -1.94% | -5.16% | -58.78% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-58.78% | 2.33Cr | |
+10.79% | 12TCr | |
+11.65% | 11TCr | |
-6.20% | 2.39TCr | |
-3.44% | 2.16TCr | |
-11.25% | 1.9TCr | |
-40.50% | 1.7TCr | |
-13.41% | 1.63TCr | |
+6.64% | 1.41TCr | |
+31.84% | 1.2TCr |
- Stock Market
- Equities
- GDTC Stock
- News CytoMed Therapeutics Limited
- CytoMed Therapeutics Limited Reports Earnings Results for the Half Year Ended June 30, 2023